Melanie Herman
About Melanie Herman
Melanie Herman serves as the Chief Accounting Officer and Interim CFO at Ligand Pharmaceuticals, a position she has held since 2015. She has a background in accounting with previous roles at KPMG LLP, CyDex Pharmaceuticals, and Entertainment Properties Trust.
Work at Ligand Pharmaceuticals
Melanie Herman has served as the Chief Accounting Officer and Interim CFO at Ligand Pharmaceuticals since 2015. In this role, she oversees the company's accounting functions and financial reporting. Her tenure at Ligand Pharmaceuticals has spanned nine years, contributing to the company's financial management and strategic initiatives in La Jolla.
Previous Experience in Accounting
Prior to her current position, Melanie Herman held several accounting roles. She worked at KPMG LLP as a Senior Accountant from 2001 to 2004, where she gained significant experience in auditing and financial consulting. Following that, she served as Assistant Controller at Entertainment Properties Trust from 2004 to 2009, and then as Controller at CyDex Pharmaceuticals, Inc. from 2009 to 2011.
Education and Expertise
Melanie Herman earned her Bachelor’s degree in Accounting and Finance from Kansas State University, completing her studies from 1997 to 2001. This educational background provided her with a solid foundation in financial principles and accounting practices, which she has applied throughout her career in various accounting and financial leadership roles.
Career Progression
Melanie Herman's career reflects a steady progression through various accounting positions. After starting her career at KPMG LLP, she transitioned to roles with increasing responsibility, including five years as Assistant Controller at Entertainment Properties Trust and two years as Controller at CyDex Pharmaceuticals, Inc. This trajectory showcases her development and expertise in the field of accounting.